Search

Financial results - NOVOCORE MEDICAL & RESEARCH S.R.L.

0.00
Financial Summary - Novocore Medical & Research S.r.l.
Unique identification code: 42215544
Registration number: J23/525/2020
Nace: 7219
Sales - Ron
176.585
Net Profit - Ron
60.679
Employees
1
Open Account
Company Novocore Medical & Research S.r.l. with Fiscal Code 42215544 recorded a turnover of 2024 of 176.585, with a net profit of 60.679 and having an average number of employees of 1. The company operates in the field of Cercetare-dezvoltare in alte stiinte naturale si inginerie having the NACE code 7219.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Novocore Medical & Research S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - 93.794 108.874 42.808 115.840 176.585
Total Income - EUR - - - - - 93.857 108.903 42.969 115.865 190.064
Total Expenses - EUR - - - - - 14.646 32.693 50.501 61.023 124.412
Gross Profit/Loss - EUR - - - - - 79.212 76.210 -7.531 54.842 65.652
Net Profit/Loss - EUR - - - - - 78.273 75.121 -7.959 54.182 60.679
Employees - - - - - 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 53.3%, from 115.840 euro in the year 2023, to 176.585 euro in 2024. The Net Profit increased by 6.800 euro, from 54.182 euro in 2023, to 60.679 in the last year.
Sales - Ron
Net Profit - Ron
Employees
See Company Data

Check the financial reports for the company - Novocore Medical & Research S.r.l.

Rating financiar

Financial Rating -
NOVOCORE MEDICAL & RESEARCH S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Novocore Medical & Research S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Novocore Medical & Research S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Novocore Medical & Research S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Novocore Medical & Research S.r.l. - CUI 42215544

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - 38.325 60.013 137.994 43.093 69.703
Current Assets - - - - - 41.032 76.033 29.362 93.318 79.988
Inventories - - - - - 0 0 0 0 0
Receivables - - - - - 16.090 63.975 15.321 67.528 60.940
Cash - - - - - 24.942 12.058 14.041 25.790 19.048
Shareholders Funds - - - - - 78.314 135.552 58.656 97.277 89.670
Social Capital - - - - - 41 40 41 40 40
Debts - - - - - 1.043 494 108.701 39.134 60.021
Income in Advance - - - - - 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7219 - 7219"
CAEN Financial Year 7219
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 79.988 euro in 2024 which includes Inventories of 0 euro, Receivables of 60.940 euro and cash availability of 19.048 euro.
The company's Equity was valued at 89.670 euro, while total Liabilities amounted to 60.021 euro. Equity decreased by -7.063 euro, from 97.277 euro in 2023, to 89.670 in 2024.
Monitors the Company

Risk Reports Prices

Reviews - Novocore Medical & Research S.r.l.

Comments - Novocore Medical & Research S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.